Bausch + Lomb, Xyoo thib ob-loj tshaj IPO, Pops hauv Public Debut

Ntawv loj

Lub tuam txhab kho qhov muag

Bausch + Lomb

thiab biotech

PepGen

ncaws tawm lawv lub neej raws li cov tuam txhab pej xeem hnub Friday. 

Ob lub tuam txhab qhib lub sijhawm qeeb rau cov teeb meem tshiab. Kev nce nyiaj txiag, kev lag luam dav dav, thiab kev ua tsov rog hauv Ukraine tau ua rau IPOs tuaj ze rau kev nres hauv 2022. Tsuas yog 39 lub tuam txhab tau mus rau pej xeem siv cov kev cai ib txwm siv txij li lub Tsib Hlis 6, nce $ 4 billion, raws li Dealogic. Qhov no piv rau 140 lub lag luam, sau $ 56.6 billion, rau tib lub sijhawm xyoo 2021. 

PepGen (ticker: PEPG) yog thawj zaug pib ua lag luam. Shares pib ntawm $ 15.60 thiab kaw ntawm $ 12.89, nce 7.4%.

Qhov debut tuaj tom qab biotech nce qhov loj ntawm nws qhov kev muab los ntawm 25% rau 9 lab shares, uas nws raug nqi $12, hauv qab nws $ 13 txog $ 15 ib feem. BofA Securities,

SVB Securities
,
thiab

Quav tawv

yog cov underwriters cov hlau lead hauv lub deal. 

PepGen tab tom nrhiav kev kho mob hnyav neuromuscular thiab neurological kab mob.

Bausch + Lomb's (BLCO) Tshuag tau nce ntau dua 11% kom xaus ntawm $ 20. 

Hnub Thursday lig, lub tuam txhab tau nce $ 630 lab tom qab muag 35 lab shares ntawm $ 18, hauv qab nws qhov kev cia siab ntawm $ 21 txog $ 24.

Morgan Stanley

thiab

Goldman Sachs

yog cov thawj coj underwriters ntawm IPO. Ntawm $ 630 lab, Bausch + Lomb muab qib thib ob-loj tshaj IPO xyoo no, tom qab $ 1 nphom muab los ntawm kev lag luam ntiag tug TPG (TPG), uas tau teev nyob rau lub Ib Hlis. 

Ntawm $ 20, Bausch + Lomb tus nqi yog $ 7 billion.

Bausch + Lomb yog lub chaw muag khoom ntawm cov lo ntsiab muag. Nws kuj muab cov khoom siv kho qhov muag, nrog rau cov tee thiab cov vitamins rau lub qhov muag. Nws yog ib qho ntawm ob lub lag luam uas niam txiv Bausch Health (BHC) tau noj pej xeem kom txo nws cov nuj nqis $ 22.9 billion. Lwm qhov yog lub tuam txhab saib xyuas tawv nqaij Solta Medical, uas tau thov rau IPO tab sis tseem tsis tau teem caij. 

Bausch + Lomb tsis tau muab cov khoom lag luam hauv nws IPO thiab yuav tsis tau txais cov nyiaj tau los ntawm kev muag khoom. Cov niam txiv tau muag tag nrho 35 lab cov khoom muaj nyob rau hauv Bausch + Lomb IPO. Bausch Health lub koom haum tuaj yeem poob mus rau 88.5% yog tias cov neeg sau ntawv siv cov kev xaiv tag nrho, ib tug prospectus hais tias.

Bausch Health yog yav dhau los Valeant Pharmaceuticals International, uas nyob rau hauv 2020 them $ 45 lab mus rau Securities thiab Exchange Commission los daws qhov kev thov ntawm kev lees paub cov nyiaj tau los tsis raug thiab kev nthuav tawm tsis tseeb hauv SEC cov ntaub ntawv thiab kev nthuav qhia nyiaj tau los. Ua siab loj tau Bausch + Lomb nyob rau hauv 2013 rau ze li $9 billion.

Sau ntawv rau Luisa Beltran ntawm [email tiv thaiv]